Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SPART: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SPART encodes spartin, a protein involved in lipid droplet metabolism, mitochondrial function, and endosomal trafficking. Mutations cause hereditary spastic paraplegia (SPG20/Troyer syndrome).
No AI portrait yet
| Gene Symbol | SPART |
| Full Name | Spartin |
| Aliases | SPG20/Troyer syndrome |
| Chromosome | 4p16.3 |
| Function | encodes a protein involved in lipid droplet metabolism, mitochondrial function, and endosomal trafficking. |
| Amino Acids | 628 aa |
| UniProt ID | Q9UQ10 |
| NCBI Gene ID | 55037 |
| Ensembl ID | ENSG00000133104 |
| OMIM | 607111 |
| GeneCards | SPART |
| Human Protein Atlas | SPART |
| Associated Diseases | neurodegeneration |
| Interactions | AMPK |
| KG Connections | 27 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
SPART["SPART gene"]
AMPK["AMPK"]
TFEB["TFEB"]
TFE3["TFE3"]
FOXO1["FOXO1"]
SQSTM1["SQSTM1/p62"]
NBR1["NBR1"]
OPTN["OPTN"]
ATG14["ATG14"]
LYSOSOMAL["Lysosomal Degradation"]
LIPOPHAGY["Lipophagy"]
PPARA["PPARA"]
SREBP1["SREBP1"]
NEURODEGENERATION["Neurodegeneration"]
ALS["ALS"]
NAFLD["NAFLD"]
AMPK -->|"activates"| SPART
SPART -->|"regulates"| LYSOSOMAL
SPART -->|"associates with"| ATG14
SPART -->|"associates with"| SQSTM1
SPART -->|"associates with"| NBR1
SPART -->|"associates with"| OPTN
TFEB -->|"regulates"| SPART
TFE3 -->|"regulates"| SPART
FOXO1 -->|"regulates"| SPART
SPART -->|"regulates"| LIPOPHAGY
LIPOPHAGY -->|"involves"| LYSOSOMAL
SQSTM1 -->|"mediates"| LYSOSOMAL
SPART -->|"associates with"| PPARA
SPART -->|"associates with"| SREBP1
SPART -->|"regulates"| NEURODEGENERATION
SPART -->|"regulates"| ALS
SPART -->|"regulates"| NAFLD
style SPART fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px
style AMPK fill:#1b5e20,stroke:#333,stroke-width:2px
style TFEB fill:#4a1a6b,stroke:#333,stroke-width:2px
style TFE3 fill:#4a1a6b,stroke:#333,stroke-width:2px
style FOXO1 fill:#4a1a6b,stroke:#333,stroke-width:2px
style LYSOSOMAL fill:#1b5e20,stroke:#333,stroke-width:2px
style LIPOPHAGY fill:#1b5e20,stroke:#333,stroke-width:2px
style NEURODEGENERATION fill:#ef5350,stroke:#333,stroke-width:2px
style ALS fill:#ef5350,stroke:#333,stroke-width:2px
style NAFLD fill:#7d4200,stroke:#333,stroke-width:2px| Target | Relation | Type | Str |
|---|---|---|---|
| Fatty Liver | regulates | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Diabetes | regulates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Nafld | regulates | disease | 0.65 |
| Atherosclerosis | regulates | disease | 0.65 |
| Lysosomal Degradation | associated_with | pathway | 0.60 |
| SREBP1 | associated_with | gene | 0.60 |
| ATG14 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEURODEGENERATION | regulates | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| LIPOPHAGY | regulates | gene | 0.60 |
| P62 | associated_with | gene | 0.60 |
| TFEB | associated_with | gene | 0.60 |
| NBR1 | associated_with | gene | 0.60 |
| FOXO1 | associated_with | gene | 0.60 |
| PPARA | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| OPTN | associated_with | gene | 0.60 |
| PPARG | associated_with | gene | 0.60 |
| VPS4A | associated_with | gene | 0.60 |
| SREBF1 | associated_with | gene | 0.60 |
| TFE3 | associated_with | gene | 0.60 |
| PSEN1 | co_discussed | gene | 0.50 |
| PRESENILIN | co_discussed | protein | 0.50 |
| AMPK | activates | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SPART in their description or question text
No additional research found